Axsome Therapeutics (AXSM) Change in Cash (2015 - 2026)
Axsome Therapeutics recorded quarterly Change in Cash of -$17.8 million in Q1 2026, down 662.16% quarter-over-quarter from -$2.3 million in Q4 2025, and down 23.43% year-over-year from -$23.3 million in Q1 2025.
Axsome Therapeutics' Change in Cash history runs 12 years deep, the most recent figure standing at -$17.8 million for Q1 2026.
- In Q1 2026, Change in Cash fell 23.43% year-over-year to -$17.8 million; the TTM figure through Mar 2026 stood at $4.2 million (up 113.74% YoY), while the FY2025 annual figure was $7.6 million, up 110.7% from the prior year.
- Change in Cash came in at -$17.8 million for Q1 2026 at Axsome Therapeutics, down from -$2.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $190.6 million in Q2 2023 to a low of -$54.8 million in Q1 2024.
- A 5-year average of $12.9 million and a median of -$11.3 million in 2022 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash soared 2687.71% in 2023 and plunged 219.88% in 2024, its largest moves.
- Axsome Therapeutics' Change in Cash stood at -$26.7 million in 2022, then retreated by 13.84% to -$30.4 million in 2023, then soared by 60.53% to -$12.0 million in 2024, then jumped by 80.49% to -$2.3 million in 2025, then tumbled by 662.16% to -$17.8 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$17.8 million, -$2.3 million, and $22.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -17.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.83 Mn |
| Dec 31, 2025 | -2.34 Mn |
| Sep 30, 2025 | 22.26 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | -14.44 Mn |
| Dec 31, 2024 | -11.99 Mn |
| Sep 30, 2024 | 11.68 Mn |
| Jun 30, 2024 | -15.78 Mn |
| Mar 31, 2024 | -54.75 Mn |
| Dec 31, 2023 | -30.37 Mn |
| Sep 30, 2023 | -20.55 Mn |
| Jun 30, 2023 | 190.60 Mn |
| Mar 31, 2023 | 45.67 Mn |
| Dec 31, 2022 | -26.68 Mn |
| Sep 30, 2022 | 154.13 Mn |
| Jun 30, 2022 | -11.31 Mn |
| Mar 31, 2022 | -1.77 Mn |
| Dec 31, 2021 | -28.15 Mn |
| Sep 30, 2021 | -26.60 Mn |
| Jun 30, 2021 | -23.44 Mn |
| Mar 31, 2021 | -19.22 Mn |
| Dec 31, 2020 | -18.48 Mn |
| Sep 30, 2020 | 11.68 Mn |
| Jun 30, 2020 | -6.63 Mn |
| Mar 31, 2020 | -22.65 Mn |
| Dec 31, 2019 | 176.32 Mn |
| Sep 30, 2019 | -10.11 Mn |
| Jun 30, 2019 | 11.13 Mn |
| Mar 31, 2019 | 28.66 Mn |
| Dec 31, 2018 | -1.25 Mn |
| Sep 30, 2018 | -5.13 Mn |
| Jun 30, 2018 | -6.28 Mn |
| Mar 31, 2018 | -7.39 Mn |
| Dec 31, 2017 | 2.35 Mn |
| Sep 30, 2017 | -6.32 Mn |
| Jun 30, 2017 | -7.03 Mn |
| Mar 31, 2017 | 8.40 Mn |
| Dec 31, 2016 | 2.73 Mn |
| Sep 30, 2016 | -4.86 Mn |
| Jun 30, 2016 | -5.33 Mn |
| Mar 31, 2016 | -3.96 Mn |
| Dec 31, 2015 | 43.42 Mn |
| Sep 30, 2015 | -1.79 Mn |
| Jun 30, 2015 | 4.72 Mn |
| Mar 31, 2015 | -927,382.00 |